What is penile calciphylaxis?

Penile Calciphylaxis

Definition and Core Pathophysiology

Penile calciphylaxis is a rare, life-threatening manifestation of calcific uremic arteriolopathy characterized by calcium deposition and occlusion of small to medium-sized arterial vessels in the penis, leading to ischemic necrosis and gangrene. 1, 2

• This condition represents a severe complication of chronic kidney disease-mineral and bone disorder (CKD-MBD), involving calcification, fibrosis, and thrombosis of dermal and subdermal vessels 1
• Penile involvement is exceedingly rare compared to other anatomic sites, but carries a particularly grave prognosis with reported 6-month mortality rates of 69% 3
• The pathophysiology involves medial and intimal calcification of small and medium penile arteries, resulting in luminal narrowing and subsequent tissue ischemia 4

Clinical Presentation

Patients typically present with painful, necrotic lesions of the glans penis or penile shaft, often with increased penile consistency progressing to complete gangrene. 2, 4

• The condition manifests as tender, necrotic plaques that evolve rapidly from initial pain and induration to frank tissue necrosis 5
• Nearly all reported cases occur in patients with end-stage renal disease (ESRD) on hemodialysis, frequently with concurrent diabetes mellitus and secondary hyperparathyroidism 2, 4
• Concomitant calciphylaxis lesions at other body sites (lower extremities, trunk) are common 2, 5

Risk Factors and Predisposing Conditions

End-stage renal disease on hemodialysis with mineral-bone disorder represents the primary risk factor, with additional contributions from hyperparathyroidism, elevated calcium-phosphate product, and diabetes. 1, 4

• Pathologically elevated parathyroid hormone (PTH), calcium, and phosphorus levels promote tissue calcium deposition 4
• A calcium-phosphate product (Ca × P) >70 mg²/dL² significantly increases risk, though calciphylaxis can occur with normal mineral levels 1
• Vitamin K antagonist use (warfarin) increases calciphylaxis risk up to 11-fold in ESRD patients 1
• Calcium-containing phosphate binders and high-dose vitamin D derivatives may contribute to calcium loading 1

Diagnostic Approach

Diagnosis is primarily clinical, supported by characteristic histopathologic findings showing vascular calcification with luminal narrowing and tissue necrosis; skin biopsy has variable sensitivity (20-80%) and carries risk of further tissue trauma. 1, 4

Key Diagnostic Elements:

• Clinical presentation: Painful necrotic penile lesions in an ESRD patient on dialysis 2, 5
• Laboratory evaluation: Elevated PTH (particularly >500 pg/mL), calcium, phosphorus, and Ca × P product; elevated C-reactive protein indicating inflammation 1, 4
• Histopathology (when performed): Ulcerative necrosis with extensive calcium deposition in small arterial walls and luminal narrowing 4
• Imaging: May show vascular calcification, though not routinely required for diagnosis 1

Critical Pitfall:

• Avoid aggressive biopsy of vulnerable necrotic tissue, as this can worsen local trauma and delay healing; diagnosis can often be made clinically in the appropriate context 1

Management Strategy

Treatment requires a multimodal approach prioritizing mineral-bone disorder correction, sodium thiosulfate therapy, meticulous wound care, and consideration of surgical debridement or penectomy based on disease severity and infection risk. 1, 2, 3

First-Line Medical Management:

Mineral-Bone Disorder Optimization:

• Reduce calcium-containing phosphate binders and adjust dialysate calcium concentration to lower levels (1.5-2.0 mEq/L) to avoid positive calcium balance 1
• Target serum phosphorus <6 mg/dL and Ca × P product <55 mg²/dL² 3
• Consider parathyroidectomy for PTH levels >500 pg/mL 1
• Discontinue vitamin K antagonists (warfarin) immediately; consider non-vitamin K oral anticoagulants if anticoagulation required 1

Sodium Thiosulfate Therapy:

• Administer 12.5-25g per hemodialysis session, 2-3 times weekly for 3-6 months 1
• This represents first-line pharmacologic intervention and has demonstrated success in penile calciphylaxis 3

Wound Care:

• Perform careful debridement of necrotic tissue, avoiding aggressive trauma to vulnerable areas 1
• Apply appropriate wound dressings with meticulous inspection and cleansing 1
• Implement strategies to minimize ongoing trauma (e.g., urinary diversion with suprapubic catheter if urinary incontinence present) 2
• Track healing progress with photographic documentation 1

Surgical Management:

Partial or complete penectomy should be considered for extensive necrosis, progressive gangrene despite conservative therapy, or signs of local infection/sepsis. 2, 4, 6

• Conservative management with wound care may suffice for small, localized lesions without infection 3
• Surgical intervention (partial penectomy) becomes necessary when disease severity precludes conservative management or when sepsis develops 6
• Penectomy may not impact overall survival given the systemic nature of the disease, but can halt local disease progression and improve quality of life 6, 3
• The decision between conservative and surgical management must be individualized based on extent of necrosis, presence of infection, and patient goals of care 2

Prognosis and Goals of Care

Penile calciphylaxis carries an extremely poor prognosis with high mortality rates, primarily from sepsis secondary to infected necrotic ulcers; early goals-of-care discussions with interdisciplinary teams are essential. 1, 2

• Six-month mortality approaches 69% in penile calciphylaxis cases 3
• Death typically results from sepsis originating from infected ulcers rather than the local penile disease itself 1
• Early collaborative discussion involving urology, nephrology, wound care specialists, palliative care, patient, and family is critical for establishing realistic treatment goals 2
• Some patients may elect palliative care over aggressive surgical intervention given the poor overall prognosis 2

Monitoring and Follow-up

Regular assessment should include wound healing evaluation, inflammatory markers (C-reactive protein), mineral-bone parameters, and surveillance for new calciphylaxis lesions at other sites. 1

• Monitor serum calcium, phosphorus, PTH, and Ca × P product to ensure therapeutic targets are maintained 1, 3
• Assess for signs of infection requiring antibiotic therapy or surgical intervention 1
• Continue sodium thiosulfate therapy for the full 3-6 month course even if initial improvement occurs 1